74 Tumor microenvironment based on PD-L1 and CD8 T-cell infiltration correlated with the response of MSS mCRC patients treated vactosertib in combination with pembrolizumab

• Chan-Young Ock,
• Keun-Wook Lee,
• Young Suk Park,
• Joong Bae Ahn,
• Jiyeon Ryu,
• Bitna Oh,
• Sunjin Hwang,
• Ki Baik Hahm,
• Seong-Jin Kim,
• Tae Won Kim,
• Hyejoo Park,
• Bo-Kyoung Kim

Affiliations

Chan-Young Ock

Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea

Keun-Wook Lee

Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, South Korea

Young Suk Park

2Samsung Medical Center, Seoul, Korea, Republic of

Joong Bae Ahn

3Yonsei Cancer Center, Seoul, Korea, Republic of

Jiyeon Ryu

5MedPacto,Inc, Seoul, Korea, Republic of

Bitna Oh

5MedPacto,Inc, Seoul, Korea, Republic of

Sunjin Hwang

5MedPacto,Inc, Seoul, Korea, Republic of

Ki Baik Hahm

5MedPacto,Inc, Seoul, Korea, Republic of

Seong-Jin Kim

5MedPacto,Inc, Seoul, Korea, Republic of

Tae Won Kim

6Asan Medical Center, Seoul, Korea, Republic of

Hyejoo Park

5MedPacto, Inc., Seoul, Korea, Republic of

Bo-Kyoung Kim

5MedPacto, Inc., Seoul, Korea, Republic of